Cited by 77Diabetes Treatment and ManagementDiabetes Management and EducationDiabetes Management and Research

Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program

Open access
Kulzer, Bernhard, Daenschel, Wilfried, Daenschel, Ingrid, Schramm, Wendelin, Messinger, Diethelm, Weissmann, Joerg, Vesper, Iris, Parkin, Christopher G. +1 more·2018·Diabetes Research and Clinical Practice

Abstract

AIMS: Globally, many patients with insulin-treated type-2 diabetes are suboptimally controlled. The PDM-ProValue study program evaluated whether integrated personalized diabetes management (iPDM) has the potential to improve clinical outcomes. METHODS: 101 practices with 907 patients participated in the 12-month, prospective, controlled, cluster-randomized study program. HbA1c levels, therapy changes, frequency of hypoglycemic episodes, patient reported outcomes, and physician satisfaction were assessed. RESULTS: iPDM led to a greater reduction in HbA1c after 12 months vs. usual care (-0.5%, p < 0.0001 vs. -0.3%, p < 0.0001), (Diff. 0.2%, p = 0.0324). Most of the HbA1c reduction occurred after 3 months and remained stable thereafter. The percentage of patients with therapy adjustments was higher in the iPDM group at all visits (p < 0.01 at week 3, month 3, month 6). Patient adherence at month 12 was higher in the iPDM group compared to baseline (Odds ratio = 2.39; p = 0.0003); also, patient treatment satisfaction (DTSQc: 12.2 vs. 10.4, δ = 1.78, p = 0.004; DTSQs: 31.0 vs. 30.0, δ = 0.924, p = 0.02), and physician satisfaction was higher in the intervention group. CONCLUSIONS: iPDM improved the use of diagnostic data leading to better glycemic control, more timely treatment adjustments (indicating reduced clinical inertia), and increased patient adherence and treatment satisfaction among patients and physicians.

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2018.09.002

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kulzer, B., Daenschel, W., Daenschel, I., Schramm, W., Messinger, D., Weissmann, J., Vesper, I., Parkin, C. G., & Heinemann, L.
Affiliations
  • Forschungsinstitut der Diabetes Akademie Mergentheim (DE)
  • Heilbronn University (DE)
  • Roche Diabetes Care GmbH (Germany) (DE)
Corresponding author
  • Kulzer, Bernhard
  • Schramm, Wendelin
  • Messinger, Diethelm
  • Weissmann, Joerg
  • Vesper, Iris
  • Parkin, Christopher G.
  • Heinemann, Lutz
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2018-10
Volume
144
Pages
200-212
ISSN
0168-8227 (ISSN-L)
OpenAlex
W2891618874
Cited by
77
References
41
Citations by year
2026: 5 · 2025: 9 · 2024: 11 · 2023: 10 · 2022: 16 · 2021: 7 · 2020: 8 · 2019: 9 · 2018: 2
FWCI
5.17
Type
journal article
Language
en
Open access
Locations
  • Diabetes Research and Clinical Practice (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Roche Diabetes Care Deutschland GmbH
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
personalized diabetes management, type 2 diabetes, insulin therapy, glycemic control, HbA1c, clinical inertia, medication adherence, treatment satisfaction, physician satisfaction, patient-reported outcomes, hypoglycemia, primary care
MeSH terms
Aged, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Prognosis, Prospective Studies, Research Design, Blood Glucose Self-Monitoring, Glycemic Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review